XORTX Therapeutics (XRTX) Current Leases (2020 - 2025)
XORTX Therapeutics (XRTX) posted Current Leases of $37287.0 for Q4 2025, down 3.86% on a QoQ basis from $38785.0 in Q4 2024, and down 3.86% year-over-year from $38785.0 in Q4 2024.
XORTX Therapeutics (XRTX) Current Leases (2020 - 2025) Analysis & Trends
XORTX Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $37287.0 for Q4 2025.
- Quarterly Current Leases fell 3.86% year-over-year to $37287.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37287.0 (down 3.86% YoY) and the FY2025 annual result came in at $37287.0, down 3.86% from the prior year.
- Current Leases was $37287.0 for Q4 2025 at XORTX Therapeutics, down from $38785.0 in the prior quarter.
- Across five years, Current Leases topped out at $16.0 million in Q4 2021 and bottomed at $11510.0 in Q4 2023.
- A 5-year average of $2.7 million and a median of $61536.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases jumped 914.74% — and 2022, when it tumbled 99.59%.
- XORTX Therapeutics' Current Leases stood at $16.0 million in 2021, then tumbled by 99.59% to $65947.4 in 2022, then tumbled by 82.55% to $11510.0 in 2023, then surged by 236.97% to $38785.0 in 2024, then declined by 3.86% to $37287.0 in 2025.
- Business Quant data shows XRTX's Current Leases at $37287.0 in Q4 2025, $38785.0 in Q4 2024, and $14037.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37,287.00 |
| Dec 31, 2024 | 38,785.00 |
| Mar 31, 2024 | 14,037.00 |
| Dec 31, 2023 | 11,510.00 |
| Sep 30, 2023 | 28,512.00 |
| Jun 30, 2023 | 45,185.00 |
| Mar 31, 2023 | 61,536.00 |
| Dec 31, 2022 | 65,947.44 |
| Sep 30, 2022 | 67,333.36 |
| Jun 30, 2022 | 67,556.04 |
| Mar 31, 2022 | 13.09 Mn |
| Dec 31, 2021 | 16.00 Mn |
| Sep 30, 2021 | 6.03 Mn |
| Dec 31, 2020 | 1.58 Mn |